Literature DB >> 11276031

Analysis of change in the presence of informative censoring: application to a longitudinal clinical trial of progressive renal disease.

M D Schluchter1, T Greene, G J Beck.   

Abstract

The rate of change in a continuous variable, measured serially over time, is often used as an outcome in longitudinal studies or clinical trials. When patients terminate the study before the scheduled end of the study, there is a potential for bias in estimation of rate of change using standard methods which ignore the missing data mechanism. These methods include the use of unweighted generalized estimating equations methods and likelihood-based methods assuming an ignorable missing data mechanism. We present a model for analysis of informatively censored data, based on an extension of the two-stage linear random effects model, where each subject's random intercept and slope are allowed to be associated with an underlying time to event. The joint distribution of the continuous responses and the time-to-event variable are then estimated via maximum likelihood using the EM algorithm, and using the bootstrap to calculate standard errors. We illustrate this methodology and compare it to simpler approaches and usual maximum likelihood using data from a multi-centre study of the effects of diet and blood pressure control on progression of renal disease, the Modification of Diet in Renal Disease (MDRD) Study. Sensitivity analyses and simulations are used to evaluate the performance of this methodology in the context of the MDRD data, under various scenarios where the drop-out mechanism is ignorable as well as non-ignorable. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11276031     DOI: 10.1002/sim.720

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

1.  Improved prediction of rates of visual field loss in glaucoma using empirical Bayes estimates of slopes of change.

Authors:  Felipe A Medeiros; Linda M Zangwill; Robert N Weinreb
Journal:  J Glaucoma       Date:  2012-03       Impact factor: 2.503

2.  Nonparametric multistate representations of survival and longitudinal data with measurement error.

Authors:  Bo Hu; Liang Li; Xiaofeng Wang; Tom Greene
Journal:  Stat Med       Date:  2012-04-26       Impact factor: 2.373

3.  Estimating evolutionary parameters when viability selection is operating.

Authors:  Jarrod D Hadfield
Journal:  Proc Biol Sci       Date:  2008-03-22       Impact factor: 5.349

Review 4.  Analytic Considerations for Repeated Measures of eGFR in Cohort Studies of CKD.

Authors:  Haochang Shou; Jesse Y Hsu; Dawei Xie; Wei Yang; Jason Roy; Amanda H Anderson; J Richard Landis; Harold I Feldman; Afshin Parsa; Christopher Jepson
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-27       Impact factor: 8.237

5.  A Semiparametric Marginalized Model for Longitudinal Data with Informative Dropout.

Authors:  Mengling Liu; Wenbin Lu
Journal:  J Probab Stat       Date:  2012-01-01

6.  Survival-adjusted health-related quality of life (HRQL) among patients with metastatic breast cancer receiving paclitaxel plus bevacizumab versus paclitaxel alone: results from Eastern Cooperative Oncology Group Study 2100 (E2100).

Authors:  David Cella; Molin Wang; Lynne Wagner; Kathy Miller
Journal:  Breast Cancer Res Treat       Date:  2011-08-27       Impact factor: 4.872

7.  Jointly modeling the relationship between longitudinal and survival data subject to left truncation with applications to cystic fibrosis.

Authors:  Annalisa V Piccorelli; Mark D Schluchter
Journal:  Stat Med       Date:  2012-07-11       Impact factor: 2.373

8.  Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).

Authors:  Jennifer J Gassman; Tom Greene; Jackson T Wright; Lawrence Agodoa; George Bakris; Gerald J Beck; Janice Douglas; Ken Jamerson; Julia Lewis; Michael Kutner; Otelio S Randall; Shin-Ru Wang
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

9.  Shared parameter models for joint analysis of longitudinal and survival data with left truncation due to delayed entry - Applications to cystic fibrosis.

Authors:  Mark D Schluchter; Annalisa V Piccorelli
Journal:  Stat Methods Med Res       Date:  2018-04-04       Impact factor: 3.021

Review 10.  Kidney disease trials for the 21st century: innovations in design and conduct.

Authors:  William G Herrington; Natalie Staplin; Richard Haynes
Journal:  Nat Rev Nephrol       Date:  2019-10-31       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.